As a drug delivery system, lipid-based formulations provide improved stability of an API and allow for safe, efficient delivery of complex drug products. Join Emergent's Andrew Griffiths, Sr. Specialist, MS&T, for our recent podcast Understanding Today's Lipid-Based Formulation Landscape in conjunction with BioPharm International to learn more about our expertise in liposome and lipid nanoparticle (LPN) development and manufacturing. Listen to the full podcast or download the transcript:
Listen to the podcast below and download the Q&A transcript here.